| 摘要 |
<p>The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The com-pounds possess valuable therapeutic properties and are particu-larly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. In formula (I) R is a moiety of the formula (R) wherein * indicates the binding site to the quinolinyl radical and wherein A, B, X', Y, Q, R1, R2, R3, R4, R5, m, n, p, q, R a, R b, X and Ar are as defined in claim 1.</p> |
| 申请人 |
ABBOTT GMBH & CO. KG |
发明人 |
TURNER, SEAN COLM;BRAJE, WILFRIED;HAUPT, ANDREAS;LANGE, UDO;DRESCHER, KARLA;WICKE, KARSTEN;UNGER, LILIANE;MEZLER, MARIO;WERNET, WOLFGANG;MAYRER, MATTHIAS |
